1.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0304011, NOVARTIS-CPTK787-0133/304946, NCT00068679
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CPTK787 0135/306241, CONFIRM 1, NCT00056459
|
|
3.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: Other
Protocol IDs: 2004-0248, NCT00088231
|
|
4.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 69
Sponsor: Other
Protocol IDs: EORTC-26041, EORTC-22041, EUDRACT-2004-003896-35, NCT00128700
|
|
5.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CPTK787 0134/306220, NCT00171587
|
|
6.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: DUMC-6626-04-12R0, NCT00303732
|
|
7.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: UCSF-04557, NCT00293371
|
|
8.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: Other
Protocol IDs: NVCI05-14, NCT00281125
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: CALGB-30107, NCT00053885
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CALGB-10105, NCT00072475
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: UMCC 2005.014, NCT00134355
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: Other
Protocol IDs: 03-257, NCT00165347
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 91411, EudraCT Nr: 2004-002290-22, 308801, NCT00160043
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: Other
Protocol IDs: PCRT04-001, NCT00226005
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-0639, IND#: 72,721, NCT00240162
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-0970, NCT00263198
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CPTK787 A2401/300267, GIST PTK787/ZK222584, NCT00117299
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CRCA-CCTC-CAMEL02, EU-20787, EUDRACT-2005-004710-33, CCTC-Camel-02, ISRCTN191981, NCT00563823
|
|
19.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: AMC-016, NOVARTIS-CPTK7870104
|
|
20.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0403067-01, NOVARTIS-CPTK7870113, NCT00091299
|
|
21.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: 05-020, NCT00268918
|
|
22.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: DUMC-7019-06-3R1, NOVARTIS-DUMC-7019-06-3R1, NCT00387933
|
|
23.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-046, NCT00358163
|
